Meridian Biosciences is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. The company was founded in 1976 and is based in Cincinnati, Ohio.
VIVO Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for VIVO, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Meridian Bioscience Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Meridian Bioscience Inc ended up being:
The company's compound free cash flow growth rate over the past 5.5 years comes in at -0.01%; that's greater than only 23.15% of US stocks we're applying DCF forecasting to.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Meridian Bioscience Inc? See A, ABC, BIO, LGND, and SNN.
Meridian Bioscience ([[VIVO]] -1.1%) announces the availability of a SARS-CoV-2 antibody pair designed specifically for the development of COVID-19 antigen tests using saliva samples.It says the antibodies recognize a linear epitope of the SARS-CoV-2 trimeric protein with picogram/mL sensitivity while avoiding reactivity with other coronaviruses such as SARS-CoV, HCoV-229F, HCoV-HKUI,...
Upgrades * For First Community Corp (NASDAQ: FCCO), Raymond James upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, First Community showed an EPS of $0.30, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.00 and a 52-week-low of $12.51. First Community closed at $13.66 at the end of the last trading period. * Raymond James upgraded American Airlines Group (NASDAQ:AAL) from Underperform to Market Perform. American Airlines shares closed at $11.39 on Friday. * Goldman Sachs upgraded Tapestry (NYSE:TPR) from Neutral to Buy. Tapestry shares closed at $13.47 on Friday. * Citigroup upgraded the previous rating for Schlumberger Ltd (NYSE: SLB) from Neutral to Buy. For the second quarter, Schlum...